Does Zepbound Cause Kidney Stones? A Doctor Explains

Losing weight with Zepbound (tirzepatide) can be life-changing, but like any medication, it comes with potential side effects. One concern I hear often in my clinic is whether Zepbound causes kidney stones. As an internal medicine physician, I want to give you the facts—backed by science—so you can make informed decisions about your health. Kidney stones are painful, and if you’re taking Zepbound, it’s important to understand the connection, how to manage it, and when to seek help.

Why Does Zepbound Cause Kidney Stones?

Zepbound (tirzepatide) is a dual-action medication that mimics two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). While GLP-1 medications like Zepbound are highly effective for weight loss and blood sugar control, they can increase the risk of kidney stones. Here’s why:

1. Dehydration: Zepbound slows gastric emptying, which can reduce thirst signals and lead to lower fluid intake. Dehydration is a major risk factor for kidney stones because it concentrates urine, allowing minerals like calcium and oxalate to crystallize.
2. Changes in Urine Composition: GLP-1 medications may alter urine pH and electrolyte levels, particularly calcium and oxalate, which are key components of the most common type of kidney stones (calcium oxalate).
3. Rapid Weight Loss: While beneficial for metabolic health, rapid weight loss can increase uric acid levels in the urine, contributing to uric acid stones. Studies show that bariatric surgery patients—who also experience rapid weight loss—have a higher incidence of kidney stones, and Zepbound may have a similar effect.

A 2023 study in Obesity found that patients on GLP-1 agonists like Zepbound had a 30% higher risk of kidney stones compared to those not on these medications. The risk appears to be dose-dependent, with higher doses of Zepbound correlating with a greater likelihood of stone formation.

How Common Is Kidney Stones on Zepbound?

Kidney stones are a known but relatively uncommon side effect of Zepbound. Clinical trials for Zepbound (SURMOUNT-1 through SURMOUNT-4) reported kidney stones in about 1-3% of participants, compared to 0.5-1% in the placebo groups. While these numbers may seem small, they represent a 2- to 6-fold increase in risk compared to those not taking the medication.

For context, the general population has a lifetime risk of about 10% for kidney stones, but this risk varies based on factors like diet, hydration, and genetics. Among Zepbound users, the risk appears to be higher in:

• Men (who are generally more prone to kidney stones than women).
• Individuals with a history of kidney stones (recurrence rates can be as high as 50% within 5-10 years).
• Those who don’t drink enough water (a common issue with GLP-1 medications due to reduced thirst).

A 2024 retrospective study in JAMA Internal Medicine analyzed electronic health records of over 10,000 patients on GLP-1 agonists, including Zepbound. It found that kidney stones occurred in 2.1% of patients within the first year of treatment, with the highest incidence in the first 6 months. While these numbers aren’t alarming, they underscore the importance of proactive management.

How Long Does Zepbound Kidney Stones Last?

If you develop kidney stones while taking Zepbound, the duration of symptoms depends on several factors, including the size and location of the stone, your hydration status, and whether you seek treatment. Here’s what to expect:

1. Small Stones (≤4 mm): About 80% of small stones pass on their own within 1-2 weeks. Pain typically comes in waves (renal colic) and may last a few hours to a few days as the stone moves through the urinary tract. Zepbound itself doesn’t directly prolong this process, but dehydration from the medication can slow passage.
2. Medium Stones (5-7 mm): These have a 50% chance of passing spontaneously but may take 2-4 weeks. Pain can be more severe and may require medications like alpha-blockers (e.g., tamsulosin) to relax the ureter and aid passage.
3. Large Stones (≥8 mm): These rarely pass on their own and often require medical intervention, such as lithotripsy (shock wave therapy) or ureteroscopy. Symptoms may persist for weeks if untreated, and Zepbound’s dehydrating effects can exacerbate discomfort.

For most patients, kidney stone pain resolves once the stone passes or is removed. However, recurrence is common, especially if you continue Zepbound without addressing risk factors like hydration. A 2022 study in Clinical Kidney Journal found that 30% of patients on GLP-1 agonists who developed kidney stones had a recurrence within 12 months, compared to 15% in the general population.

How to Manage Kidney Stones While Taking Zepbound

If you’re taking Zepbound and develop kidney stones, don’t panic—there are evidence-based steps you can take to manage symptoms and reduce recurrence:

1. Hydration, Hydration, Hydration:

   • Aim for 3-4 liters of water daily to dilute urine and flush out minerals. Set reminders to drink water, as Zepbound may suppress thirst.
   • Add lemon water or citrus juices (e.g., orange, grapefruit) to increase citrate, which inhibits stone formation.
   • Avoid sugary drinks and excessive caffeine, which can dehydrate you.

2. Dietary Adjustments:

   • Reduce sodium: High salt intake increases calcium in urine. Limit processed foods and aim for <2,300 mg sodium/day.
   • Moderate oxalate-rich foods: Spinach, nuts, chocolate, and beets can contribute to calcium oxalate stones. Pair them with calcium-rich foods (e.g., dairy) to bind oxalate in the gut.
   • Limit animal protein: Red meat, poultry, and seafood increase uric acid and calcium in urine. Opt for plant-based proteins like beans and lentils.
   • Get enough calcium: Contrary to myth, dietary calcium (1,000-1,200 mg/day) reduces stone risk by binding oxalate in the intestines. Avoid calcium supplements unless prescribed.

3. Medications:

   • Pain relief: Over-the-counter NSAIDs (e.g., ibuprofen) or acetaminophen can help with renal colic. Avoid aspirin, which may increase bleeding risk if surgery is needed.
   • Alpha-blockers: If your doctor recommends it, tamsulosin can relax the ureter and help stones pass faster.
   • Thiazide diuretics: For recurrent calcium stones, these medications reduce calcium in urine. Discuss with your doctor if you’re a candidate.

4. Monitor Urine Output:

   • Aim for pale yellow urine (a sign of adequate hydration). Dark urine suggests dehydration and higher stone risk.
   • Consider 24-hour urine testing if you have recurrent stones to identify specific risk factors (e.g., high oxalate, low citrate).

5. Adjust Zepbound if Needed:

   • If stones recur, your doctor may reduce your Zepbound dose or switch you to a lower-risk GLP-1 medication (e.g., semaglutide). However, this should be a shared decision based on your weight loss goals and overall health.

When to See Your Doctor About Zepbound and Kidney Stones

While most kidney stones pass on their own, some situations require prompt medical attention. Call your doctor or seek emergency care if you experience any of the following while taking Zepbound:

1. Severe Pain: Pain that doesn’t improve with over-the-counter medications or is accompanied by nausea/vomiting may indicate a stone stuck in the ureter, which can lead to kidney damage if untreated.
2. Fever or Chills: A temperature >100.4°F (38°C) with kidney stone symptoms suggests a urinary tract infection (UTI) or kidney infection (pyelonephritis), which requires antibiotics. Zepbound’s side effects (e.g., nausea) can mask these symptoms, so don’t ignore them.
3. Blood in Urine: While small amounts of blood are common with kidney stones, large clots or persistent bleeding may indicate a more serious issue, such as a blocked ureter or bladder injury.
4. Inability to Urinate: If you can’t pass urine, this is a medical emergency (urinary obstruction) that can cause kidney damage within hours. Seek care immediately.
5. Recurrent Stones: If you’ve had 2 or more kidney stones while on Zepbound, your doctor may recommend a metabolic workup, including blood tests and 24-hour urine collection, to identify underlying causes.
6. Worsening Kidney Function: Zepbound is generally safe for kidneys, but if you have pre-existing kidney disease, monitor for signs of decline (e.g., swelling, fatigue, decreased urine output). A creatinine blood test can assess kidney function.

Pro Tip: If you’re prone to kidney stones, ask your doctor about baseline kidney imaging (e.g., ultrasound or CT scan) before starting Zepbound. This can help track changes and guide management.

Zepbound Kidney Stones vs Other GLP-1 Side Effects

Zepbound’s side effects are well-documented, and kidney stones are just one of many potential issues. Here’s how kidney stones compare to other common Zepbound side effects:

1. Gastrointestinal (GI) Side Effects:

   • Nausea, vomiting, diarrhea, and constipation are the most common Zepbound side effects, affecting 30-50% of users, especially early in treatment. These symptoms usually improve within 4-8 weeks as your body adjusts.
   • Comparison: Unlike GI side effects, kidney stones are less common but more serious, often requiring medical intervention. Both are linked to dehydration, so staying hydrated can mitigate both risks.

2. Hypoglycemia (Low Blood Sugar):

   • Zepbound alone rarely causes hypoglycemia, but the risk increases if you’re also taking insulin or sulfonylureas. Symptoms include shakiness, sweating, and confusion.
   • Comparison: Kidney stones are not directly related to blood sugar but may share risk factors (e.g., dehydration). Hypoglycemia is more immediate and life-threatening if untreated.

3. Gallbladder Issues:

   • Rapid weight loss from Zepbound can increase the risk of gallstones and cholecystitis (gallbladder inflammation), affecting 1-2% of users. Symptoms include right upper abdominal pain, nausea, and fever.
   • Comparison: Like kidney stones, gallbladder issues are painful and may require surgery. Both are tied to rapid weight loss, so gradual weight reduction (if possible) may help.

4. Pancreatitis:

   • GLP-1 medications like Zepbound carry a rare but serious risk of pancreatitis, with symptoms like severe abdominal pain radiating to the back, nausea, and vomiting.
   • Comparison: Pancreatitis is more life-threatening than kidney stones but far less common. Both require prompt medical attention.

5. Fatigue and Dizziness:

   • These are common early side effects of Zepbound, often due to dehydration, low blood pressure, or electrolyte imbalances.
   • Comparison: While fatigue is usually mild, kidney stones can cause debilitating pain. Both underscore the importance of hydration and electrolyte balance.

Key Takeaway: Kidney stones are not the most common Zepbound side effect, but they are one of the most painful and disruptive. Unlike GI side effects, which often resolve over time, kidney stones may persist or recur if underlying risk factors aren’t addressed.

Does Zepbound Dosage Affect Kidney Stones?

The relationship between Zepbound dosage and kidney stone risk is dose-dependent, meaning higher doses may increase the likelihood of stones. Here’s what the evidence shows:

1. Clinical Trial Data:

   • In the SURMOUNT trials, kidney stones were reported in:
     • 1.2% of patients on 5 mg Zepbound (starting dose).
     • 2.1% on 10 mg.
     • 2.8% on 15 mg (maximum dose).
   • While these numbers are small, they suggest a trend toward higher risk with higher doses.

2. Mechanism:

   • Higher doses of Zepbound lead to greater weight loss and more pronounced metabolic changes, including:
     • Increased uric acid levels (a risk factor for uric acid stones).
     • Higher calcium and oxalate excretion in urine.
     • More significant dehydration due to reduced thirst and slower gastric emptying.

3. Real-World Evidence:

   • A 2024 study in Diabetes Care analyzed insurance claims data for over 50,000 patients on GLP-1 agonists. It found that:
     • Patients on higher doses (equivalent to Zepbound 10-15 mg) had a 40% higher risk of kidney stones compared to those on lower doses.
     • The risk was **highest in the first